TrialEuropean journal of nuclear medicine and molecular imaging2023

A hybrid radioactive and fluorescence approach is more than the sum of its parts; outcome of a phase II randomized sentinel node trial in prostate cancer patients.

Esther M K Wit et al.PubMed ↗Publisher ↗

No numbers read from the abstract.